Cellcyte Genetics Corp.
CIK 0001325279
Revenue (TTM)
—
Q3 Nov 2014
Net Income (TTM)
−$129.69K
−128.0% YoY
Q3 Nov 2014
EPS Diluted (TTM)
$0.00
−100.0% YoY
Q3 Nov 2014
Gross Margin
—
Q3 Nov 2014
Operating Margin
—
Q3 Nov 2014
Net Margin
—
Q3 Nov 2014
Free Cash Flow (TTM)
—
Q3 Nov 2014
Cash
−$31.86K
Q3 Nov 2014
Total Debt
$358.61K
Q3 Nov 2014
Shares Outstanding
82.33M sh
Q3 Nov 2014
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.